SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-009862
Filing Date
2022-04-27
Accepted
2022-04-27 16:00:31
Documents
45
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20220331_10q.htm   iXBRL 10-Q 414038
2 EXHIBIT 31.1 ex_361835.htm EX-31.1 11330
3 EXHIBIT 31.2 ex_361836.htm EX-31.2 11309
4 EXHIBIT 32.1 ex_361837.htm EX-32.1 3396
5 EXHIBIT 32.2 ex_361838.htm EX-32.2 4612
  Complete submission text file 0001437749-22-009862.txt   2090262

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA govx-20220331.xsd EX-101.SCH 26391
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20220331_cal.xml EX-101.CAL 23071
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20220331_def.xml EX-101.DEF 161066
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20220331_lab.xml EX-101.LAB 151982
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20220331_pre.xml EX-101.PRE 175967
39 EXTRACTED XBRL INSTANCE DOCUMENT govx20220331_10q_htm.xml XML 148229
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 22859406
SIC: 2834 Pharmaceutical Preparations